US 8901279
Humanized antibodies with anti-tumor activity
granted A61KA61K2039/505A61P
Quick answer
US patent 8901279 (Humanized antibodies with anti-tumor activity) held by TEVA PHARMACEUTICALS AUSTRALIA PTY LTD expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
- Grant date
- Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00